Porcine malignant hyperthermia. III: Adrenergic blockade

Area of Science:

• Veterinary Anesthesiology
• Pharmacology
• Animal Models

Background:

• Malignant hyperthermia (MH) is a severe hypermetabolic crisis triggered by volatile anesthetics and succinylcholine.
• Porcine models are crucial for understanding MH pathophysiology and testing therapeutic interventions.
• Adrenergic pathways are implicated in MH, but their precise role remains under investigation.

Purpose of the Study:

• To investigate the effects of adrenergic blockade on suxamethonium-induced malignant hyperthermia in Pietrain pigs.
• To determine the efficacy of alpha-adrenergic (phentolamine) and beta-adrenergic (propranolol) blockade, as well as reserpine, in preventing MH.

Main Methods:

• Pietrain pigs were administered reserpine, followed by suxamethonium challenge.
• Separate groups of pigs received either phentolamine or propranolol prior to and during suxamethonium administration.
• Physiological parameters, including temperature and survival rates, were monitored.

Main Results:

• Reserpine pre-treatment resulted in a 50% mortality rate from suxamethonium-induced MH.
• Pigs treated with propranolol (beta-blockade) all developed fatal MH.
• Pigs treated with phentolamine (alpha-adrenergic blockade) survived suxamethonium challenge, but initial abnormal muscle responses persisted.

Conclusions:

• Alpha-adrenergic blockade with phentolamine appears to prevent fatal hyperthermia in suxamethonium-challenged pigs.
• Beta-adrenergic blockade and reserpine did not protect against MH.
• These findings suggest a critical role for alpha-adrenergic pathways in the susceptibility to and/or manifestation of porcine malignant hyperthermia.